DPRXP7

Across TCGA pan-cancer cohorts, DPRXP7 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of DPRXP7’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where DPRXP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DPRXP7 is over-expressed in tumor, although a few such as BRCA and KIRP show the opposite, repressed pattern.

THCA, BRCA, and KIRP are the cancer types where DPRXP7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DPRXP7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	+0.169	<.001	6	view →
BRCA	All	All	−0.011	.029	2	view →
KIRP	Female	All	−0.046	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

DPRXP7–THCA

Open the THCA breakdown →